1. Br J Haematol. 2020 Oct;191(2):e52-e55. doi: 10.1111/bjh.16992. Epub 2020 Jul 
25.

First reported case of BRAF V600E mutation in T-cell prolymphocytic leukaemia.

Dong S(1), Khedro T(1), Ward P(2), Dubeau L(2), Yaghmour B(3), Siddiqi I(2), 
Yaghmour G(1).

Author information:
(1)Jane Anne Nohl Division of Hematology and Center for the Study of Blood 
Diseases, Keck School of Medicine of University of Southern California, Los 
Angeles, CA, USA.
(2)Department of Pathology, Keck School of Medicine of University of Southern 
California, Los Angeles, CA, USA.
(3)Pulmonary, Critical Care, Keck School of Medicine of University of Southern 
California, Los Angeles, CA, USA.

DOI: 10.1111/bjh.16992
PMCID: PMC9007147
PMID: 32712959 [Indexed for MEDLINE]

Conflict of interest statement: Conflicts of interest The authors do not have a 
conflict of interest. GY discloses that he is a pharmaceutical board speaker for 
Jazz Pharmaceuticals, Astellas, and Takeda. He is also a Board Adviser for Jazz 
and AstraZeneca.